Accolade, Inc. (NASDAQ:ACCD) Receives Consensus Rating of “Hold” from Brokerages

Shares of Accolade, Inc. (NASDAQ:ACCD) have earned an average rating of “Hold” from the fourteen ratings firms that are currently covering the company, MarketBeat.com reports. Thirteen investment analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $6.51.

A number of analysts have weighed in on the stock. Stephens restated an “equal weight” rating and issued a $7.03 target price on shares of Accolade in a research report on Wednesday, February 12th. Piper Sandler downgraded Accolade from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 5th.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. Longfellow Investment Management Co. LLC bought a new stake in Accolade during the 1st quarter worth approximately $74,000. Laird Norton Wetherby Trust Company LLC purchased a new position in Accolade in the fourth quarter valued at approximately $38,000. Ground Swell Capital LLC purchased a new position in shares of Accolade during the 1st quarter valued at $86,000. Boothbay Fund Management LLC bought a new position in Accolade during the fourth quarter worth about $43,000. Finally, Wealth Enhancement Advisory Services LLC bought a new position in Accolade in the 4th quarter worth approximately $48,000. 84.99% of the stock is owned by institutional investors and hedge funds.

Accolade Price Performance

ACCD stock opened at $7.02 on Tuesday. The firm has a 50-day moving average price of $7.01 and a 200-day moving average price of $5.83. Accolade has a 12 month low of $3.08 and a 12 month high of $7.75. The company has a current ratio of 2.63, a quick ratio of 2.63 and a debt-to-equity ratio of 0.67. The stock has a market capitalization of $575.59 million, a P/E ratio of -3.12 and a beta of 2.10.

Accolade Company Profile

Accolade, Inc, together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and primary care physicians.